FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:839 February 24, 2005 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Ferriero, D. M. PubMed Citation

To the Editor: In an otherwise superbly informative article, Ferriero (Nov. 4 issue)¹ failed to include medication-induced causes of neonatal seizures in Table 2, which shows the differential diagnosis of neonatal seizures according to the day of presentation. This is a serious omission.² The Canadian Adverse Drug Reaction Monitoring Program issued an advisory on August 9, 2004, for pregnant mothers who take selective serotonin-reuptake inhibitors (SSRIs). The Canadian program reported possible seizures in newborns, particularly in the newborns of women who took these antidepressants in the third trimester of pregnancy.³ Laine et al. reported that neonates were at risk for . . . [Full Text of this Article]

This article has been cited by other articles:

• Coulombier, D., Ekdahl, K. (2005). H5N1 influenza and the implications for Europe. BMJ 331: 413-414 [Full Text]